Cargando…

Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer

Monocarboxylate Transporter 2 (MCT2) is a major pyruvate transporter encoded by the SLC16A7 gene. Recent studies pointed to a consistent overexpression of MCT2 in prostate cancer (PCa) suggesting MCT2 as a putative biomarker and molecular target. Despite the importance of this observation the mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pertega-Gomes, Nelma, Vizcaino, Jose R., Felisbino, Sergio, Warren, Anne Y., Shaw, Greg, Kay, Jonathan, Whitaker, Hayley, Lynch, Andy G., Fryer, Lee, Neal, David E., Massie, Charles E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673295/ https://www.ncbi.nlm.nih.gov/pubmed/26035357

Ejemplares similares

Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer
por: Valença, Isabel, et al.
Publicado: (2015)

Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2011)

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
por: Pertega‐Gomes, Nelma, et al.
Publicado: (2015)

Deafness and loss of cochlear hair cells in the absence of thyroid hormone transporters Slc16a2 (Mct8) and Slc16a10 (Mct10)
por: Sharlin, David S., et al.
Publicado: (2018)

Butyric acid increases transepithelial transport of ferulic acid through upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4)
por: Ziegler, Kerstin, et al.
Publicado: (2016)

Identification of potential therapeutic targets in prostate cancer through a cross‐species approach
por: Jurmeister, Sarah, et al.
Publicado: (2018)

Prognostic Value of SLC16A3(MCT4) in Lung Adenocarcinoma and Its Clinical Significance
por: Xue, Lei, et al.
Publicado: (2021)

Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs)
por: Pértega-Gomes, Nelma, et al.
Publicado: (2013)

MCT8 deficiency in a patient with a novel frameshift variant in the SLC16A2 gene
por: Wakabayashi, Kei, et al.
Publicado: (2021)

A lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancer
por: Pértega-Gomes, Nelma, et al.
Publicado: (2014)

Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity
por: Shih, Hung-Ju, et al.
Publicado: (2012)

Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
por: Pértega-Gomes, Nelma, et al.
Publicado: (2014)

Mammalian monocarboxylate transporter 7 (MCT7/Slc16a6) is a novel facilitative taurine transporter
por: Higuchi, Kei, et al.
Publicado: (2022)

Three novel mutations of the MCT8 (SLC16A2) gene: individual and temporal variations of endocrinological and radiological features
por: Ono, Erina, et al.
Publicado: (2016)

A SLC16A1 Mutation in an Infant With Ketoacidosis and Neuroimaging Assessment: Expanding the Clinical Spectrum of MCT1 Deficiency
por: Al-Khawaga, Sara, et al.
Publicado: (2019)

Histological characterization of orphan transporter MCT14 (SLC16A14) shows abundant expression in mouse CNS and kidney
por: Roshanbin, Sahar, et al.
Publicado: (2016)

Monocarboxylate Transporter 13 (MCT13/SLC16A13) Functions as a Novel Plasma Membrane Oligopeptide Transporter
por: Higuchi, Kei, et al.
Publicado: (2023)

Untargeted metabolomics identifies the potential role of monocarboxylate transporter 6 (MCT6/SLC16A5) in lipid and amino acid metabolism pathways
por: Ren, Tianjing, et al.
Publicado: (2022)

Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer
por: Pinto, Filipe, et al.
Publicado: (2016)

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
por: Curry, Joseph M., et al.
Publicado: (2013)

Increased Oxidative Metabolism and Neurotransmitter Cycling in the Brain of Mice Lacking the Thyroid Hormone Transporter Slc16a2 (Mct8)
por: Rodrigues, Tiago B., et al.
Publicado: (2013)

Indole Derivatives as New Structural Class of Potent and Antiproliferative Inhibitors of Monocarboxylate Transporter 1 (MCT1; SLC16A1)
por: Puri, Sachin, et al.
Publicado: (2022)

HES5 silencing is an early and recurrent change in prostate tumourigenesis
por: Massie, Charles E, et al.
Publicado: (2015)

Lactate Transporter SLC16A3 (MCT4) as an Onco-Immunological Biomarker Associating Tumor Microenvironment and Immune Responses in Lung Cancer
por: Tao, Qingsong, et al.
Publicado: (2022)

Regulation of the localisation and function of the oncogene LYRIC/AEG‐1 by ubiquitination at K486 and K491
por: Luxton, Hayley J., et al.
Publicado: (2014)

Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer
por: Barquilha, Caroline N., et al.
Publicado: (2020)

Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression
por: Tseng, H-Y, et al.
Publicado: (2017)

The oncogene Mct-1 promotes progression of hepatocellular carcinoma via enhancement of Yap-mediated cell proliferation
por: Yang, Wenjie, et al.
Publicado: (2021)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

Inhibition of Hypothalamic MCT4 and MCT1–MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions
por: Elizondo-Vega, Roberto, et al.
Publicado: (2019)

Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer
por: Bisetto, Sara, et al.
Publicado: (2018)

Oncogenic epigenetic control
por: Stein, Gary S., et al.
Publicado: (2016)

Insights Into the Mechanism of MCT8 Oligomerization
por: Groeneweg, Stefan, et al.
Publicado: (2020)

A common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility
por: Nakayama, Akiyoshi, et al.
Publicado: (2013)

Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells
por: Kershaw, Stephen, et al.
Publicado: (2015)

Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
por: Sheng, Gaohong, et al.
Publicado: (2023)

Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4
por: Martinez-Outschoorn, Ubaldo E, et al.
Publicado: (2013)

Critical Velocity, Maximal Lactate Steady State, and Muscle MCT1 and MCT4 after Exhaustive Running in Mice
por: Orsi, Juan B., et al.
Publicado: (2023)

The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
por: Shaw, Greg L., et al.
Publicado: (2016)

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
por: Zecchini, Vincent, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ju2cgai6j6fogthg6jc9jibvq8